Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.
$ONEOK Inc (OKE.US)$ : “I think Oneok is terrific. I would indeed buy more.”
$DexCom (DXCM.US)$ : “Dexcom had a real bad miss. They still really haven’t fully explained why that is...I’d stay away from De...
0.9900.981
+28.95%
-0.92%
Sangamo Enters License Agreement With Genentech To Develop Intravenously Administered Genomic Medicines For Neurodegenerative Diseases; Co. Expected To Receive $50M In Near-Term Upfront License Fees And Is Eligible For Up To $1.9B In Milestones
尘埃落定,既成事实,这样的话,投资者们也就放心了。
still confuse about this waterfall
blowing out my mine
No comment yet